切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2010, Vol. 04 ›› Issue (06) : 729 -733. doi: 10.3877/cma.j.issn.1674-0807.2010.06.016

临床研究

三阴性乳腺癌患者血清白细胞介素8和环氧化酶2的含量及临床意义
李庆1, 陈守华1, 顾禾1, 张丽丽1   
  1. 1.250014 济南,山东大学附属千佛山医院普外中心
  • 收稿日期:2009-07-13 出版日期:2010-12-01

Expressions of serum IL-8 and COX-2 in triple negative breast cancer patients and clinical significance

Qing LI1, Shou-hua CHEN1, He GU1, Li-li ZHANG1   

  1. 1.Department of General Surgery, Qianfoshan Hospital, Shandong University.Jinan 250014,China
  • Received:2009-07-13 Published:2010-12-01
引用本文:

李庆, 陈守华, 顾禾, 张丽丽. 三阴性乳腺癌患者血清白细胞介素8和环氧化酶2的含量及临床意义[J/OL]. 中华乳腺病杂志(电子版), 2010, 04(06): 729-733.

Qing LI, Shou-hua CHEN, He GU, Li-li ZHANG. Expressions of serum IL-8 and COX-2 in triple negative breast cancer patients and clinical significance[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2010, 04(06): 729-733.

目的

探讨三阴性乳腺癌患者手术前、后血清白细胞介素8(IL-8)、环氧化酶2(COX-2)表达变化及临床意义。

方法

采用酶联免疫吸附测定-双抗体夹心法(enzyme linked immunosorbent assay sandwich technique,ELISA)检测手术前、后72例乳腺癌患者(乳腺癌组)和54例良性乳腺肿物患者(对照组)血清IL-8、COX-2的表达。血清IL-8、COX-2含量在两组间比较采用t检验。术前与术后比较和术后与术后1年比较采用配对t检验。

结果

手术前乳腺癌组血清IL-8、COX-2表达明显高于对照组(P 值均是0.000)。手术后乳腺癌组与对照组比较血清IL-8、COX-2表达差异均无统计学意义(P>0.050)。乳腺癌组手术前血清IL-8、COX-2表达明显高于手术后(P 值均是0.000)。72例乳腺癌患者中术后1年内复发4例;4例复发患者术后和术后1年血清IL-8、COX-2水平均高于无复发患者(P 值均<0.050)。

结论

乳腺癌患者手术前、后IL-8和COX-2水平变化显著,可能对判断治疗效果有一定的参考意义。

Objective

To explore the expressions of serum interlueukin-8(IL-8)and cyclooxygenase-2(COX-2)in triple negative breast cancer patients before and after surgery and their clinical significance.

Methods

Specimens from 72 triple negative breast cancer patients(the breast cancer group)and 54 patients with benign breast mass (the control group)before and after operation were selected.The expressions of IL-8 and COX-2 in both groups before and after surgery were assessed using enzyme linked immunosorbent assay-sandwich technique(ELISA).Student's t test was used for the comparison of the expressions of IL-8 and COX-2 between the two groups,and paired t test was used for the comparison between pre-operation and post-operation.

Results

Before surgery the expression levels of IL-8 and COX-2 in the breast cancer group was markedly higher than in the control group(both P=0.000),but after operation there was no statistical difference between the two groups(both P>0.050).The expression levels of IL-8 and COX-2 before operation were higher than after operation in the breast cancer group(both P=0.000).Among the 72 breast cancer patients,postoperative recurrence occurred in 4,and their IL-8 and COX-2 expression levels were higher than those of the nonrecurrence patients(both P>0.050).

Conclusions

The changes of the expressions of IL-8 and COX-2 in triple negative breast cancer patients before and after operation are obvious and may be helpful to judge therapeutic effect.

表1 两组患者手术前、后血清IL-8、COX-2的含量变化
表2 复发与无复发患者术后和术后1年血清IL-8、COX-2的含量
[1]
Simeone AM,Nieves-Alicea R,Mc Murtry VC,et al.Cyclooxygenase-2 uses the protein kinase C/interleukin-8/urokinasetype plasminogen activator pathway to increase the invasiveness of breast cancer cells.Int J Oncol,2007,30:785-792.
[2]
Lin Y,Huang R,Chen L,et al.Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays.Int J Cancer,2004,109:507-515.
[3]
Singh B,Berry JA,Vincent LE,et al.Involvement of IL-8 in COX-2 mediated bone metastasis from breast cancer.J Surg Res,2006,134:44-51.
[4]
李铁芬,Tilton B,袁永辉,等.IL-8在食管癌中表达对肿瘤血管形成及患者预后的影响.华中科技大学学报(医学版),2005,34:451-453.
[5]
Tsuji M,Kaman S,Tsuji S,et al.Cycloxygenase regulates angiogenesis induced by colon cancer cells.Cell,1998,93:705-716.
[6]
Su JL,Shih JY,Yen ML,et al.Cyclooxygenase-2 induces EP1-and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation:a novel mechanism of lymphangiogenesis in lung adenocarcinoma.Cancer Res,2004,64:554-564.
[7]
Kyzas PA,Stafanou D,Agnaatis NJ.COX-2 expression correlates with VEGF-Cand lymph node metastases in patients with head and neck squamous cell carcinoma.Mod Pathol,2005,18:153-160.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[4] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[5] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[6] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[7] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[8] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[9] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[10] 葛睿, 陈飞, 李杰, 李娟娟, 陈涵. 多基因检测在早期乳腺癌辅助治疗中的应用价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 257-263.
[11] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[12] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[13] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[14] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[15] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
阅读次数
全文


摘要